FIT screening reduces risk for advanced CRC

Population-based fecal immunochemical test screening was effective at reducing risk for advanced colorectal cancer and associated mortality, according to study results.Tony Hsiu-Hsi Chen, PhD, from National Taiwan University, and colleagues wrote that there is an urgent need to evaluate the long-term effectiveness of FIT screening in population-based programs.“Previous studies have demonstrated that FIT is less sensitive for detecting proximal advanced neoplasm than distal ones, whether the long-term effectiveness of FIT in reducing mortality from CRC and advanced-stage CRC also variesRead More

Share on facebook
Share on twitter
Share on linkedin